<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126080">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01921374</url>
  </required_header>
  <id_info>
    <org_study_id>DMDK</org_study_id>
    <nct_id>NCT01921374</nct_id>
  </id_info>
  <brief_title>Mother-caregivers of Children With Duchenne Muscular Dystrophy</brief_title>
  <acronym>DMDK</acronym>
  <official_title>Profile of Mother-caregivers of Children With Duchenne Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monica Levy Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <authority>Brazil: Ministério da Saúde and Ethical Committee of Federal University of Sao Paulo.</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of Duchenne Muscular Dystrophy (DMD) is approximately 1 in 3.500 male
      newborns. During its progression there is loss of mobility, swallowing difficulties and a
      significant reduction in respiratory capacity. Due to the severity and consequences, is
      inevitable the need for a caregiver, that normally rely the mother.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Duchenne Muscular Dystrophy (DMD) is a neuromuscular disease characterized by genetic
      alteration, whose consequence is the progression of muscle degeneration.  The
      mother-caregiver dedicates herself entirely to her son, putting aside the care of their
      physical and psychological health. The responsibility and workload to care for the child is
      high. Because of this extreme amount of work associated with other factors such as stress,
      this mothers-caregivers are more likely to develop hypertension, respiratory disease,
      susceptibility to infections, depression, anxiety, insomnia, impaired immune and
      cardiovascular problems. Moreover, they are more likely to develop sleep disorders, those
      who may cause a high health risk, since many sleep disorders are related to cardiovascular,
      respiratory, neurological and immune systems.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>sleep patterns of the study population</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Since the mother-caregiver dedicates herself entirely to her son, we will performe overnight polysomnography to assess the sleep pattern.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormonal profile</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Insulin Cortisol Luteinizing hormone (LH) Follicle-stimulating hormone (FSH) Total Testosterone Estradiol Progesterone Vitamin B12 Adrenocorticotropic hormone (ACTH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory profile</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
C-reactive protein (PCR) Immunoglobulin A (IgA) Immunoglobulin G (IgG) Immunoglobulin M (IgM) Complement (C3) Complement (C4) Interleukin 6 Interleukin 10 Interleukin 1β Interleukin 2 Interleukin 4 Interleukin 8 Interferon-gamma (IFN-γ) Endothelin Prostaglandin E2 Intercellular Adhesion Molecule 1 (ICAM) Vascular cell adhesion protein 1 (VCAM) Tumor necrosis factor (TNFα) Adiponectin Leptin Cysteine Lymphocytes subpopulations (T e B)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular profile</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Homocysteine Myoglobin Cardiac troponin I Creatine kinase (CK) Creatine kinase MB (CKMB)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic profile</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters:
Glucose Total cholesterol and fractions Triglycerides Uric acid Creatinine Urea Sodium Potassium Hemogram Erythrocyte sedimentation rate Natriuretic Peptide B</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Other Diseases or Conditions</condition>
  <arm_group>
    <arm_group_label>sleep parameters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the sleep parameters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cardiovascular parameters</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>To assess the cardiovascular profile of control mothers and caregivers-mothers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>imflammatory and immunological profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the inflammatory profile of caregivers-mothers and control mothers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hormonal profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the hormonal profile of caregivers-mothers and control mothers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metabolic profile</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess the health profile of caregivers-mothers and control mothers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>sleep parameters</intervention_name>
    <description>Since the mother-caregiver dedicates herself entirely to her son, we will performe overnight polysomnography to assess the sleep pattern.</description>
    <arm_group_label>sleep parameters</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Hormonal profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters.</description>
    <arm_group_label>hormonal profile</arm_group_label>
    <other_name>Insulin</other_name>
    <other_name>Cortisol</other_name>
    <other_name>Luteinizing hormone (LH)</other_name>
    <other_name>Follicle-stimulating hormone (FSH)</other_name>
    <other_name>Total Testosterone</other_name>
    <other_name>Estradiol</other_name>
    <other_name>Progesterone</other_name>
    <other_name>Vitamin B12</other_name>
    <other_name>Adrenocorticotropic hormone (ACTH)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Inflammatory profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>imflammatory and immunological profile</arm_group_label>
    <other_name>C-reactive protein (PCR)</other_name>
    <other_name>Immunoglobulin A (IgA)</other_name>
    <other_name>Immunoglobulin G (IgG)</other_name>
    <other_name>Immunoglobulin M (IgM)</other_name>
    <other_name>Complement (C3)</other_name>
    <other_name>Complement (C4)</other_name>
    <other_name>Interleukin 6</other_name>
    <other_name>Interleukin 10</other_name>
    <other_name>Interleukin 1β</other_name>
    <other_name>Interleukin 2</other_name>
    <other_name>Interleukin 4</other_name>
    <other_name>Interleukin 8</other_name>
    <other_name>Interferon-gamma (IFN-γ)</other_name>
    <other_name>Endothelin</other_name>
    <other_name>Prostaglandin E2</other_name>
    <other_name>Intercellular Adhesion Molecule 1 (ICAM)</other_name>
    <other_name>Vascular cell adhesion protein 1 (VCAM)</other_name>
    <other_name>Tumor necrosis factor (TNFα)</other_name>
    <other_name>Adiponectin</other_name>
    <other_name>Leptin</other_name>
    <other_name>Cysteine</other_name>
    <other_name>Lymphocytes subpopulations (T e B)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cardiovascular profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>cardiovascular parameters</arm_group_label>
    <other_name>Homocysteine</other_name>
    <other_name>Myoglobin</other_name>
    <other_name>Cardiac troponin I</other_name>
    <other_name>Creatine kinase (CK)</other_name>
    <other_name>Creatine kinase MB (CKMB)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Metabolic profile</intervention_name>
    <description>To assess the health profile of caregivers-mothers are analyzed some markers that may indicate an impairment or damage to the health of each of the parameters</description>
    <arm_group_label>metabolic profile</arm_group_label>
    <other_name>Glucose</other_name>
    <other_name>Total cholesterol and fractions</other_name>
    <other_name>Triglycerides</other_name>
    <other_name>Uric acid</other_name>
    <other_name>Creatinine</other_name>
    <other_name>Urea</other_name>
    <other_name>Sodium</other_name>
    <other_name>Potassium</other_name>
    <other_name>Hemogram</other_name>
    <other_name>Erythrocyte sedimentation rate</other_name>
    <other_name>Natriuretic Peptide B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mothers-caregivers of children and adolescents with DMD

          -  Mothers of children and adolescents without any neuromuscular disease and that does
             not have any chronic disease (bronchiolitis obliterates, cystic fibrosis, a genetic
             syndrome)

        Exclusion Criteria:

          -  Volunteers with low levels of education (voluntary functional illiterate) that
             prevents the questionnaires and understanding of the guidelines made

          -  Working mothers of nocturnal period
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Monica L Andersen, Professor</last_name>
    <phone>55 11 21490155</phone>
    <phone_ext>160</phone_ext>
    <email>ml.andersen12@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karen T Nozoe, Student</last_name>
    <phone>55 11 21490155</phone>
    <phone_ext>288</phone_ext>
    <email>ka.nozoe@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Federal of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04024001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica L Andersen, Professor</last_name>
      <phone>55 11 21490155</phone>
      <phone_ext>160</phone_ext>
      <email>ml.andersen12@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Karen T Nozoe, Student</last_name>
      <phone>55 11 21490155</phone>
      <phone_ext>288</phone_ext>
      <email>ka.nozoe@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Monica L Andersen, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen T Nozoe, Student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.sleepresearchsociety.org/</url>
    <description>Sleep research society</description>
  </link>
  <link>
    <url>http://www.afip.com.br/conteudo.asp?conteudo=22</url>
    <description>Site about Neuromuscular diseases</description>
  </link>
  <reference>
    <citation>Donders J, Taneja C. Neurobehavioral characteristics of children with Duchenne muscular dystrophy. Child Neuropsychol. 2009 May;15(3):295-304. doi: 10.1080/09297040802665777. Epub 2009 Jan 22.</citation>
    <PMID>19160150</PMID>
  </reference>
  <reference>
    <citation>Draper BM, Poulos CJ, Cole AM, Poulos RG, Ehrlich F. A comparison of caregivers for elderly stroke and dementia victims. J Am Geriatr Soc. 1992 Sep;40(9):896-901.</citation>
    <PMID>1512385</PMID>
  </reference>
  <reference>
    <citation>Fee RJ, Hinton VJ. Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr. 2011 Nov;32(9):644-50. doi: 10.1097/DBP.0b013e318235d614.</citation>
    <PMID>22008789</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 19, 2013</lastchanged_date>
  <firstreceived_date>August 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Monica Levy Andersen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Duchenne;</keyword>
  <keyword>mothers caregivers;</keyword>
  <keyword>sleep;</keyword>
  <keyword>hormonal profile;</keyword>
  <keyword>cardiac profile;</keyword>
  <keyword>biochemical profile;</keyword>
  <keyword>inflammatory profile.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Follicle Stimulating Hormone</mesh_term>
    <mesh_term>Beta-Endorphin</mesh_term>
    <mesh_term>Interleukin-2</mesh_term>
    <mesh_term>Interleukin-4</mesh_term>
    <mesh_term>Dinoprostone</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Immunoglobulin A</mesh_term>
    <mesh_term>Immunoglobulin G</mesh_term>
    <mesh_term>Immunoglobulin M</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Interferon-gamma</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
